Gujarat Inject (Kerala) Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 1 million compared to INR 0.119 million a year ago. Revenue was INR 1 million compared to INR 0.145 million a year ago. Net income was INR 0.024 million compared to net loss of INR 0.002 million a year ago.
For the nine months, sales was INR 1.74 million compared to INR 0.226 million a year ago. Revenue was INR 5.76 million compared to INR 0.278 million a year ago. Net income was INR 0.35 million compared to net loss of INR 0.313 million a year ago. Basic earnings per share from continuing operations was INR 0.07 compared to basic loss per share from continuing operations of INR 0.06 a year ago. Diluted earnings per share from continuing operations was INR 0.07 compared to diluted loss per share from continuing operations of INR 0.06 a year ago.